Abpro Holdings, Inc. (ABPO) Form 10-K Annual Reports
Abpro Holdings, Inc. (ABPO) is a publicly traded company on the OTC, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ABPO
CIK: 1893219
Exchange: OTC
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Wolf & Company, P.C.
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerPiro Sassa
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 25-NSE | 2026-09-30 | — | 25-NSE Filing | 0001354457-26-000926 | View SEC Doc Filr Page |
| 8-K | 2026-09-01 | 2026-08-25 | CURRENT REPORT | 0001213900-26-095822 | View SEC Doc Filr Page |
| 8-K | 2026-08-25 | 2026-08-19 | CURRENT REPORT | 0001213900-26-093599 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | QUARTERLY REPORT | 0001213900-26-090028 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-11 | — | SCHEDULE 13G/A Filing | 0000886982-26-000358 | View SEC Doc Filr Page |
| 8-K | 2026-06-04 | 2026-05-28 | CURRENT REPORT | 0001213900-26-065372 | View SEC Doc Filr Page |
| 10-Q | 2026-05-20 | 2026-03-31 | QUARTERLY REPORT | 0001213900-26-059646 | View SEC Doc Filr Page |
| NT 10-Q | 2026-05-15 | 2026-03-31 | NOTIFICATION OF LATE FILING | 0001213900-26-057769 | View SEC Doc Filr Page |
| 10-K/A | 2026-05-01 | 2025-12-31 | AMENDMENT NO. 1 TO FORM 10-K | 0001213900-26-050498 | View SEC Doc Filr Page |
| 10-K | 2026-04-15 | 2025-12-31 | ANNUAL REPORT | 0001213900-26-044166 | View SEC Doc Filr Page |
| NT 10-K | 2026-03-31 | 2025-12-31 | NOTIFICATION OF LATE FILING | 0001213900-26-036634 | View SEC Doc Filr Page |
| 8-K | 2026-02-20 | 2026-02-18 | CURRENT REPORT | 0001213900-26-018819 | View SEC Doc Filr Page |
| 8-K | 2026-02-11 | 2026-02-05 | CURRENT REPORT | 0001213900-26-014903 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-02-09 | — | SCHEDULE 13G Filing | 0000886982-26-000040 | View SEC Doc Filr Page |
| 8-K | 2026-02-03 | 2026-01-28 | CURRENT REPORT | 0001213900-26-011462 | View SEC Doc Filr Page |
| 8-K | 2026-01-23 | 2026-01-16 | CURRENT REPORT | 0001213900-26-007215 | View SEC Doc Filr Page |
| 8-K | 2026-01-06 | 2026-01-06 | CURRENT REPORT | 0001213900-26-001570 | View SEC Doc Filr Page |
| 8-K | 2025-12-15 | 2025-12-15 | CURRENT REPORT | 0001213900-25-121446 | View SEC Doc Filr Page |
| 8-K | 2025-12-09 | 2025-12-09 | CURRENT REPORT | 0001213900-25-119439 | View SEC Doc Filr Page |
| EFFECT | 2025-12-02 | — | EFFECT Filing | 9999999995-25-003479 | View SEC Doc Filr Page |
| CORRESP | 2025-12-02 | — | CORRESP Filing | 0001213900-25-116917 | View SEC Doc Filr Page |
| S-1/A | 2025-11-28 | — | AMENDMENT NO. 1 TO FORM S-1 | 0001213900-25-116002 | View SEC Doc Filr Page |
| 424B3 | 2025-11-17 | — | PROSPECTUS SUPPLEMENT | 0001213900-25-111538 | View SEC Doc Filr Page |
| 10-Q | 2025-11-14 | 2025-09-30 | QUARTERLY REPORT | 0001213900-25-110972 | View SEC Doc Filr Page |
| S-1 | 2025-11-07 | — | REGISTRATION STATEMENT | 0001213900-25-107374 | View SEC Doc Filr Page |